Samer Kaba's most recent trade in Alimera Sciences Inc. was a trade of 18,750 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 7, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alimera Sciences Inc. | Samer Kaba | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 18,750 | 18,750 | - | - | Employee Stock Option (Right to Buy) | |
Alimera Sciences Inc. | Samer Kaba | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 6,250 | 14,929 (0%) | 0% | 0 | Common Stock |